Quick Answer
BIODESIX INC reported Operating Income Loss of -$27.87 million for the year ending 2025.
- BIODESIX INC showed an increase of +19.2% in Operating Income Loss from 2024 to 2025.
- This data is from BIODESIX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), BIODESIX INC's Operating Income Loss has declined by 4.2%.
- Historical annual values: Fiscal year 2025: -$27.87 million | Fiscal year 2024: -$34.50 million | Fiscal year 2023: -$41.34 million | Fiscal year 2022: -$50.59 million | Fiscal year 2021: -$40.94 million | Fiscal year 2020: -$22.93 million | Fiscal year 2019: -$26.74 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: